Featured Research

from universities, journals, and other organizations

Children who have their adenoids out do not get fewer upper respiratory infections, study finds

Date:
September 6, 2011
Source:
BMJ-British Medical Journal
Summary:
Children who have their adenoids surgically removed do not get fewer upper respiratory tract infections such as sinusitis and colds, new research finds.

Children who have their adenoids surgically removed do not get fewer upper respiratory tract infections such as sinusitis and colds, finds research published online in the British Medical Journal.

Upper respiratory tract infections are extremely common in children and many of them are referred for ear, nose and throat (ENT) surgery. Indeed, having adenoids taken out (adenoidectomy) is one of the most frequently performed surgical procedures in children in western countries, says the study.

One of the main reasons adenoidectomy is performed is to reduce the incidence of upper respiratory tract infections. However, the clinical effectiveness of the procedure in children with recurrent upper respiratory tract infections is lacking, say the authors, led by Professor Anne Schilder from the University Medical Centre Utrecht.

Schilder and colleagues studied a group of 111 children aged between one and six selected for adenoidectomy, half of them were assigned to have the operation, the other half initially not.

The research took place between April 2007 and October 2010 across 11 general hospitals and two academic centres in the Netherlands. The participants were followed up for 24 months after surgery.

The results show that the children in the adenoidectomy group had 7.91 episodes of upper respiratory tract infections per person compared with 7.84 episodes in the other group. Days of absence from school or day care, and health related quality of life, was similar in both groups.

The findings also reveal that the prevalence of upper respiratory tract infections decreased over time for both groups.

In conclusion the authors say "in children selected for adenoidectomy for recurrent upper respiratory tract infections, a strategy of immediate surgery confers no clinical benefits over a strategy of initial watchful waiting."

In an accompanying editorial, Professor Kari Kvaerner from Oslo University Hospital concurs that the best way for health professionals to treat children with recurrent upper respiratory tract infections appears to be "careful follow-up and a strategy of watchful waiting."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. T. A. van den Aardweg, C. W. B. Boonacker, M. M. Rovers, A. W. Hoes, A. G. M. Schilder. Effectiveness of adenoidectomy in children with recurrent upper respiratory tract infections: open randomised controlled trial. BMJ, 2011; 343 (sep06 1): d5154 DOI: 10.1136/bmj.d5154

Cite This Page:

BMJ-British Medical Journal. "Children who have their adenoids out do not get fewer upper respiratory infections, study finds." ScienceDaily. ScienceDaily, 6 September 2011. <www.sciencedaily.com/releases/2011/09/110906191636.htm>.
BMJ-British Medical Journal. (2011, September 6). Children who have their adenoids out do not get fewer upper respiratory infections, study finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/09/110906191636.htm
BMJ-British Medical Journal. "Children who have their adenoids out do not get fewer upper respiratory infections, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/09/110906191636.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins